It was recently reported that IDO1 acts as an effector and an indicator of protective immune responses in patients with acute hepatitis B. The activation of IDO1 is vigorous in the early phase and is a hallmark of successful HBV clearance in patients with acute hepatitis [21]. The gene discussed is IDO1; the disease is hepatitis B virus infection.